美股市场个股详情

AKAN Akanda

添加自选

0.0905
-0.0064-6.60%

收盘价 05/03 16:00 (美东)

0.0900
-0.0005-0.55%

盘后 17:19 (美东)

289.74万总市值-12市盈率TTM

Akanda股票讨论区

登录发表评论

Traitor94

4小时前

$Akanda(AKAN.US)$ good time to buy in cheap and no shorties 👀

wwwarrior

5小时前

$Akanda(AKAN.US)$ Is everybody selling? Dear God, chill hahahaha.
Guess it has to go all the way down to .08 or even. 05 before it will go up again, sheesh.

Strike freedom

9小时前

$Akanda(AKAN.US)$ today can go up to what price?

steven smith38

11小时前

$Akanda(AKAN.US)$ 0.1300 big number

Thomas_koh

05/02 19:46

$Akanda(AKAN.US)$ why premarket drop so much?

Keol90

05/02 14:15

Looking for advice..

$Akanda(AKAN.US)$ what is the risk factor for this stock? All online reviews are different... nothing similar....

Stock_Drift

05/02 10:20

5/2/24 jj’s Watchlist.🚨🚨🚨

$Bruush Oral Care(BRSH.US)$$Akanda(AKAN.US)$$Aptevo Therapeutics(APVO.US)$$Allarity Therapeutics(ALLR.US)$$Faraday Future Intelligent Electric Inc.(FFIE.US)$
📊⚡️📊

zine1

05/02 06:36

$Akanda(AKAN.US)$ The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug as soon as Tuesday, CBS News has learned, a historic shift to generations of American drug policy that could have wide ripple effects across the country.
The DEA's proposal, which still must be reviewed by the White House Office of Management and Budget, would recognize the medical uses of cannabis and acknowledge it has less potential for abuse than some of the nation's most da...

zine1

05/02 06:22

$Akanda(AKAN.US)$ The DEA announcement has already injected billions of dollars into the publicly traded cannabis market.
The total economic impact generated by marijuana sales could surpass $112.4 billion in 2024, up a 12% from last year

zine1

05/02 06:18

$Akanda(AKAN.US)$ Currently, in the U.S., cannabis businesses exist under a crippling tax burden, often exceeding 70%, according to industry reports. The DEA’s reclassification to a Schedule III drug could significantly reduce these taxes, bringing them more in line with other controlled substances. This would translate to improved profitability for cannabis companies, boosting their bottom lines and potentially fueling future growth

暂无评论

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议

美股

综合热度